Perbedaan Lippo Cikarang Tbk dan Prodia Diagnostic Line Tbk: Lippo Cikarang Tbk diperdagangkan di Rp615 (kapitalisasi pasar 3,11 T, volume 24 jam 575 rb), sedangkan Prodia Diagnostic Line Tbk diperdagangkan di Rp270 (kapitalisasi pasar 474,07 M, volume 24 jam 21,23 jt). Perbedaan utamanya: Lippo Cikarang Tbk jauh lebih besar — sekitar 6,6× kapitalisasi pasar Prodia Diagnostic Line Tbk, dan Prodia Diagnostic Line Tbk lebih aktif diperdagangkan (21,23 jt vs 575 rb). Mana yang lebih baik tergantung tujuan investasimu.
| LPCK | PRDL | |
|---|---|---|
Kapitalisasi Pasar | 3,11 T | 474,07 M |
Volume | 575 rb | 21,23 jt |
Lot | 5,75 rb | 212,3 rb |
Perputaran | 345,35 jt | 5,77 M |
Harga Rata-rata | 600,61 | 271,63 |
Nilai Transaksi | 345,35 jt | 5,77 M |
Harga Ekuilibrium Indikatif | 615 | 270 |
Volume Ekuilibrium Indikatif | 100 | 2,21 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Lippo Cikarang Tbk was established in the Republic of Indonesia the framework of the Domestic Capital Investment Law on July 20, 1987 based on Notarial Deed No.43 of Hendra Karyadi, S.H., as amended by Notarial Deed No. 63 of the same notary dated April 22, 1998.
Selengkapnya di halaman LPCK →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Selengkapnya di halaman PRDL →